Featured
-
-
Article
| Open Access
A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease
Different classes of biologic therapeutics have been assessed in the context of Vogt-Koyanagi-Harada disease. Here the authors compared cyclosporine immunosuppression or adalimumab in a randomised clinical trial for the treatment of patients with Vogt-Koyanagi-Harada disease and found non-inferiority upon treatment with cyclosporine.
- Zhenyu Zhong
- , Lingyu Dai
- & Peizeng Yang
-
Matters Arising
| Open AccessTransplantation of discarded livers: the complementary role of normothermic regional perfusion
- Chris J. C. Johnston
- , Ahmed E. Sherif
- & Gabriel C. Oniscu
-
Article
| Open Access
Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
ER+ breast cancer patients treated with endocrine therapies often acquire resistance and develop metastasis. In this study, the authors demonstrate that endocrine therapies can promote the self-renewal of CD133hi/ERlodrug resistant cells with metastatic potential driven through the IL6-Notch3 axis activation.
- Pasquale Sansone
- , Claudio Ceccarelli
- & Jacqueline Bromberg
-
Article
| Open Access
Identification of an allosteric binding site for RORγt inhibition
Upon the binding of small ligands, nuclear receptors regulate the transcription of genes that are associated with a number of disease mechanisms. Here, the authors report on a novel allosteric ligand binding site on the nuclear receptor RORγt.
- Marcel Scheepstra
- , Seppe Leysen
- & Luc Brunsveld
-
Article |
The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia
Bronchopulmonary dysplasia (BPD) is a severe pulmonary complication seen in preterm infants, the molecular mechanisms of which are not clear. Here the authors establish a link between NLRP3 inflammasome activation, leading to production of pro-inflammatory cytokine IL1β, and the development of BPD.
- Jie Liao
- , Vishal S. Kapadia
- & Rashmin C. Savani
-
Article
| Open Access
CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis
The complement system contributes to chronic inflammatory diseases. Here the authors show that CRTP6 suppresses the alternative complement pathway and reverses rheumatoid arthritis in a mouse model of the disease.
- Masanori A. Murayama
- , Shigeru Kakuta
- & Yoichiro Iwakura
-
Article
| Open Access
NELL-1 in the treatment of osteoporotic bone loss
The growth factor NELL-1 induces bone formation during development, but its role in osteoporosis is unknown. This study shows that NELL-1 binding to integrin ß1 induces Wnt/ß-catenin signalling in the bone and restores bone mineral density in osteoporotic mice and sheep, suggesting the therapeutic potential of NELL-1 for the treatment of bone loss.
- Aaron W. James
- , Jia Shen
- & Chia Soo
-
Article
| Open Access
Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
Endometriosis is a painful condition in which endometrial cells are found outside the womb. Here, the authors identify a peptide that specifically binds to a receptor expressed on endometrial epithelial cells and use it to induce apoptosis in both cultured cells and baboons with endometriosis.
- K. Sugihara
- , Y. Kobayashi
- & M.N. Fukuda
-
Article |
Model-based rational design of an oncolytic virus with improved therapeutic potential
Oncolytic viruses can serve as self-replicating anticancer agents. Le Bœuf et al. combine synthetic modelling and molecular biology approaches to create a virus with enhanced oncolytic activity in vitro and in vivodue to its expression of an interferon antagonist.
- Fabrice Le Bœuf
- , Cory Batenchuk
- & John C. Bell
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials